IOX1 epigenetically enhanced photothermal therapy of 3D-printing silicene scaffolds against osteosarcoma with favorable bone regeneration
Materials Today Bio · 2023-12 · 23 · 100887
DOI: 10.1016/j.mtbio.2023.100887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2023-12. Verfasst von Yimin Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 2000…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China, Shanghai Medical College, Fudan University.
Abstract (Originalsprache)
Osteosarcoma (OS) is the third most common malignancy in adolescence. Currently, the treatments of OS confront great obstacles of tumor recurrence and critical bone defects after surgery, severely affecting the survival rates and living qualities of patients. Hence, it is urged to develop distinct biomaterials with both efficient tumor therapeutic and osteogenic functions. Although photothermal therapy (PTT) has aroused expanding interest, characterizing negligible invasiveness and high spatiotemporal adjustment, few studies discussed its drawbacks, such as thermal injury to adjacent normal tissue and exceeded laser power density, implying that focusing on sensitizing OS to PTT instead of simply elevating the laser power density may be a fresh way to enhance the PTT efficacy and attenuate the side/adverse effects. Herein, we successfully constructed 3D-printing silicene bioactive glass scaffolds with preferable PTT efficacy at the second near-infrared (NIR-II) biowindow and outstanding osteogenic biofunctions owing to the release of bioactive elements during degradation. Impressively, a histone demethylase inhibitor, IOX1, was introduced before PTT to sensitize OS to thermal therapy and minimize the side/adverse effects. This work offered a distinctive paradigm for optimizing the PTT efficacy of osteogenic scaffolds against OS with epigenetic modulation agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200011, China.
- Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
- Department of Orthopedics, Shanghai Sixth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200233, China.
- Department of Stomatology, Shanghai Xuhui District Dental Center, Shanghai, 200032, China.
Förderung
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Shanghai Medical College, Fudan University
Zitieren
APA
Liang, Y., Wang, C., Yu, S., Fan, Y., Jiang, Y., Zhou, R., Yan, W., & Sun, Y. (2023). IOX1 epigenetically enhanced photothermal therapy of 3D-printing silicene scaffolds against osteosarcoma with favorable bone regeneration. Materials Today Bio, 23, 100887. https://doi.org/10.1016/j.mtbio.2023.100887
Vancouver
Liang Y, Wang C, Yu S, Fan Y, Jiang Y, Zhou R, et al. IOX1 epigenetically enhanced photothermal therapy of 3D-printing silicene scaffolds against osteosarcoma with favorable bone regeneration. Materials Today Bio. 2023;23:100887. doi:10.1016/j.mtbio.2023.100887
BibTeX
@article{Liang2023,
author = {Liang, Yimin and Wang, Chunmeng and Yu, Shiyang and Fan, Yujia and Jiang, Yuhang and Zhou, Renpeng and Yan, Wangjun and Sun, Yangbai},
title = {IOX1 epigenetically enhanced photothermal therapy of 3D-printing silicene scaffolds against osteosarcoma with favorable bone regeneration},
journal = {Materials Today Bio},
year = {2023},
volume = {23},
pages = {100887},
doi = {10.1016/j.mtbio.2023.100887}
}
EUVIMED